Organoidsciences Ltd. (KOSDAQ:476040)

Organoidsciences Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	1,953	1,591	438.24
Revenue Growth (YoY)	22.77%	263.05%	-
Cost of Revenue	42.8	44.5	26.26
Gross Profit	1,910	1,547	411.98
Selling, General & Admin	8,563	6,211	4,560
Research & Development	5,217	4,776	6,227
Other Operating Expenses	32.11	44.04	38.26
Operating Expenses	14,145	11,341	10,965
Operating Income	-12,235	-9,795	-10,553
Interest Expense	-3,190	-5,992	-4,906
Interest & Investment Income	481.1	924.75	582.06
Currency Exchange Gain (Loss)	19.26	18.98	-
Other Non Operating Income (Expenses)	3,226	-24,068	-9,235
EBT Excluding Unusual Items	-11,699	-38,911	-24,111
Gain (Loss) on Sale of Investments	163.05	43.05	-
Pretax Income	-11,536	-38,868	-24,111
Earnings From Continuing Operations	-11,536	-38,868	-24,111
Minority Interest in Earnings	289.06	180.86	-
Net Income	-11,246	-38,687	-24,111
Net Income to Common	-11,246	-38,687	-24,111
Shares Outstanding (Basic)	4	3	3
Shares Outstanding (Diluted)	4	3	3
Shares Change (YoY)	45.84%	-	-
EPS (Basic)	-2690.83	-13499.65	-8413.46
EPS (Diluted)	-2690.83	-13499.65	-8413.46
Free Cash Flow	-9,808	-8,196	-10,304
Free Cash Flow Per Share	-2346.59	-2859.93	-3595.68
Gross Margin	97.81%	97.20%	94.01%
Operating Margin	-626.38%	-615.62%	-2407.94%
Profit Margin	-575.78%	-2431.56%	-5501.84%
Free Cash Flow Margin	-502.11%	-515.13%	-2351.33%
EBITDA	-10,931	-8,651	-9,748
D&A For EBITDA	1,304	1,144	804.46
EBIT	-12,235	-9,795	-10,553
Advertising Expenses	332.07	139.83	145.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.